In line, we have reviewed its expression in various cancer entities and discussed its potential clinical significance, including a meta-analysis correlating KIF2C’s expression with the OS of BC, NSCLC and HCC patients. This evidence concerns the gene KIF2C and hepatocellular carcinoma.